Furthermore, in a mouse model of SMA, it has been shown that mutation of SMN causes a reduction of muscle cell secretion of C1q/TNF-Related Protein 3 (CTRP3), which in turn regulates axonal LPS via the mTOR pathway, including SMN itself [257]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.